Tag Archives: Italian

Precision Medicine Treatment: Gene-Targeting Mesothelioma

Precision Medicine Treatment: Gene-Targeting Mesothelioma

A new precision medicine treatment for mesothelioma comes from scientists in Italy. This form of mesothelioma occurs after asbestos exposure in people with a genetic mutation. The mutation is represented by patients with an inherited cancer syndrome. These patients typically have an even worse prognosis than other mesothelioma patients. But the Italian team came up with a way to target the mutated gene. This form of treatment is called precision medicine. Precision medicine treatment looks at the genetics of a patient to select a treatment that will work best for them. Discovery of a DNA Gene Mutation Malignant pleural mesothelioma is a rare and aggressive cancer caused by exposure to asbestos. Malignant mesothelioma is one of the most aggressive kinds … Continue reading Precision Medicine Treatment: Gene-Targeting Mesothelioma »

Asbestos Exposure in Construction Workers Leads to Mesothelioma

Asbestos Exposure in Construction Workers Leads to Mesothelioma

Asbestos exposure in construction workers remains a particular concern. Malignant mesothelioma is a rare cancer with a global incidence. Italy is among the countries with the highest values of mesothelioma. Mesothelioma is associated with exposures to asbestos fibers and other asbestiform fibers. Asbestos exposure in construction workers remains a particular concern. A new study describes the characteristics of Italian malignant mesothelioma cases among construction workers. Scientists analyzed 31,572 cases with definite asbestos exposure in the period from 1993 to 2018. Connecting Asbestos Exposure and Mesothelioma in Construction Workers The relation between asbestos use and the historical trend of mesothelioma is clear. Italian scientists assessed asbestos exposure in 78.2% of the mesothelioma cases. This accounts for 24,864 of the patients studied. … Continue reading Asbestos Exposure in Construction Workers Leads to Mesothelioma »

A Multimodality Treatment Plan may be Best for Pleural Mesothelioma

A Multimodality Treatment Plan may be Best for Pleural Mesothelioma

A multimodality treatment plan may improve mesothelioma patient outcomes. Malignant pleural mesothelioma is an invasive, locally aggressive tumor related to asbestos exposure. A new study shows that the best treatment plan for pleural mesothelioma may be when different types of therapy work together. The ideal combination of treatment therapies is still unknown. But a recent study encourages further studies on a multimodality treatment plan. This may include chemotherapy, surgery, and adjuvant radiotherapy. Current Clinical Guidelines: A History of Single or Multimodality Treatment Plans Despite a long history of clinical research, there is still no cure or any evidence of the best treatment. Many single-treatment plans, single-modality plans, have had disappointing results. Researchers have begun to evaluate different multi-modal treatment approaches. … Continue reading A Multimodality Treatment Plan may be Best for Pleural Mesothelioma »

Peritoneal Mesothelioma Rates Higher in Italy’s Asbestos-Producing Regions

Some Italian workers are paying a high price for Italy’s former position as the top European producer of asbestos. According to a new study in the American Journal of Industrial Medicine, both men and women who lived and worked in areas of heavy asbestos production are far more likely than their peers elsewhere in the country to contract peritoneal mesothelioma. Peritoneal mesothelioma is the rarer form of a very rare cancer. While the more common pleural mesothelioma occurs in the membranes around the lungs, peritoneal mesothelioma starts on the membrane that surrounds abdominal organs. Like all forms of mesothelioma, it is asbestos-related, hard to treat, aggressive, and usually lethal. To get an idea how prevalent peritoneal mesothelioma is in Italy … Continue reading Peritoneal Mesothelioma Rates Higher in Italy’s Asbestos-Producing Regions »